Research programme: transported prodrugs - XenoPort

Drug Profile

Research programme: transported prodrugs - XenoPort

Alternative Names: Acamprosate prodrug; Propofol prodrug - XenoPort; XP 20925

Latest Information Update: 25 Feb 2011

Price : $50

At a glance

  • Originator XenoPort
  • Class Alkanesulfonic-acids; Phenols; Small molecules
  • Mechanism of Action GABA A receptor agonists; GABA receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Parkinson's disease
  • Suspended Fragile X syndrome
  • Discontinued Migraine; Nausea and vomiting

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top